Paper
RSC Advances
was removed under vacuum to give corresponding 1-benzyl-4- 1H); 13C NMR (75.4 MHz, CDCl3): d 51.65 (CH2), 120.43 (ArCH),
phenyl-1H-1,2,3-triazole, in excellent yield (96%) as well as 122.42 (ArCH), 122.96 (ArCH), 127.61 (ArCH), 130.02 (ArCH),
purity.
130.38 (ArCH), 130.58 (ArCH), 132.15 (ArC), 133.77 (ArC), 137.29
All the compounds were adequately characterised by phys- (ArCH), 148.22 (ArC), 148.98 (ArCH), 149.95 (ArC); HRMS: mass
ical as well as chemical methods. Spectral data of unknown calculated for [C14H11ClN4]: 271.0750 [M + H]+ and 293.0570 [M
compounds is summarised below. For original spectra of + Na]+; obs. mass: 271.0745 [M + H]+ and 293.0564 [M + Na]+.
unknown compounds please see ESI.†
2-(1-(4-Nitrobenzyl)-1H-1,2,3-triazol-4-yl)
pyridine,
4gc.
1-(4-Chlorobenzyl)-4-p-tolyl-1H-1,2,3-triazole, 4bb. Off-white Yellow solid; M.P.: 156–159 ꢁC; IR (neat): 2918, 2848, 2342, 1594,
solid; M.P.: 140–143 ꢁC; IR (neat): 2917, 2359, 1716, 1559, 1568, 1543, 1515, 1430, 1418, 1352, 1228, 1121, 1079, 995, 783
1489, 1340, 1219, 1089, 1048, 848, 754, 723 cmꢀ1; 1H NMR (300 cmꢀ1; H NMR (300 MHz, CDCl3): d 5.73 (s, 2H), 7.25–7.29 (m,
1
MHZ, CDCl3): d 2.38 (s, 3H), 5.55 (s, 2H), 7.23 (d, 2H, J ¼ 7.8 Hz), 1H), 7.48 (d, 2H, J ¼ 8.4 Hz), 7.79–7.84 (m, 1H), 8.17 (s, 1H),
7.27 (d, 2H, J ¼ 2.4 Hz), 7.35–7.38 (m, 2H), 7.38 (d, 2H, J ¼ 1.8 8.20–8.27 (m, 3H), 8.57 (d,1H J ¼ 4.8 Hz); 13C NMR (75.4 MHz,
Hz), 7.64 (s, 1H), 7.70 (d, 2H, J ¼ 8.4 Hz);13C NMR (75.4 MHz, CDCl3): d 53.35 (CH2), 120.62 (ArCH), 122.71 (ArCH), 123.29
CDCl3): d 21.27 (CH3), 53.47 (CH2), 119.09 (ArCH), 125.64 (ArCH), 124.38 (ArCH), 128.78 (ArCH), 137.73 (ArCH), 141.35
(ArCH), 127.48 (ArC), 129.36 (ArCH), 129.37(ArCH), 129.52 (ArC), 148.18 (ArC), 148.73 (ArCH), 149.37 (ArC), 156.28(ArC);
(ArCH), 133.22 (ArC), 134.84 (ArC), 138.19 (ArC), 148.36 (ArC); HRMS: mass calculated for [C14H11N5O2]: 282.0991 [M + H]+ and
HRMS: mass calculated for [C16H14ClN3]: 284.0955 [M + H]+ and 304.0810 [M + Na]+; obs. mass: 282.0986 [M + H]+ and 304.0805
306.0774 [M + Na]+; obs. mass: 284.0949 [M + H]+ and 306.0768 [M + Na]+.
[M + Na]+.
Ethyl 2-(4-(pyridin-2-yl)-1H-1 2 3-triazol-1-yl) acetate, 4hc.
1-(4-Methoxybenzyl)-4-p-tolyl-1H-1,2,3-triazole, 4eb. Yellow- Grey solid; M.P.: 117–120 ꢁC; IR (neat): 3165, 3042, 2969, 2345,
brown solid; M.P. 132–135 ꢁC; IR (neat): 3091, 2917, 1716, 1742, 1712, 1684, 1610, 1545, 1440, 1215 cmꢀ1; H NMR (300
1
1599, 1513, 1456, 1108, 1078, cmꢀ1; 1H NMR (300 MHz, CDCl3): MHz, CDCl3): d 1.32 (t, 3H, J ¼ 7.2 Hz), 4.30 (q, 2H, J ¼ 7.2 Hz),
d 2.37 (s, 3H), 3.82 (s, 3H), 5.51 (s, 2H), 6.93 (d, 2H, J ¼ 8.7 Hz), 5.24 (s, 2H), 7.28–7.30 (d,1H, J ¼ 9 Hz), 7.81–7.87 (t, 1H, J ¼ 7.8
7.21–7.29 (m, 4H), 7.60 (s, 1H),7.69 (d, 2H, J ¼ 8.1 Hz); 13C NMR Hz), 8.23 (d, 1H, J ¼ 7.8 Hz), 8.37 (s, 1H), 8.61 (d, 1H, J ¼ 4.5 Hz);
(75.4 MHz, CDCl3): d 21.27 (CH3), 53.79 (CH2), 55.35 (OCH3), 13C NMR (75.4 MHz, CDCl3): d 14.07 (CH3), 51.08 (CH2), 62.57
114.51 (ArCH), 118.97 (ArCH), 125.61 (ArCH), 126.65 (ArC), (CH2), 120.42 (ArCH), 122.99 (ArCH), 123.51 (ArCH), 137.05
127.69 (ArC), 129.50 (ArCH), 129.68 (ArCH), 137.99 (ArC), (ArCH), 148.69 (ArCH), 149.97 (ArC), 149.31 (ArC), 166 (C]O);
148.16(ArC), 159.95(ArC); HRMS: mass calculated for HRMS: mass calculated for [C11H12N4O2]: 233.1039 [M + H]+ and
[C17H17N3O]: 280.1450 [M + H]+ and 302.1269 [M + Na]+; obs. 255.0858 [M + Na]+; obs. mass: 233.1033 [M + H]+ and 255.0852
mass: 280.1444 [M + H]+ and 302.1264 [M + Na]+.
[M + Na]+.
1-(2-Chlorobenzyl)-4-p-tolyl-1H-1,2,3-triazole, 4. White
4-((1-(4-Chlorobenzyl)-1H-1, 2, 3-triazol-4-yl) methoxy) benzal-
solid; M.P.: 115–118 ꢁC; IR (neat): 2359, 1498, 1475, 1447, 1353, dehyde, 4bd. Off white solid; M.P.: 108–110 ꢁC; IR (neat): 3100,
1
1221, 1116, 1080, 1048, 836, 774, 752, 697 cmꢀ1; H NMR (300 2918, 1675, 1601, 1572, 1507, 1457, 1160, 1112, 772, 756 cmꢀ1
;
MHz, CDCl3): d 2.38 (S, 3H), 5.72 (s, 2H), 7.22 (s, 1H), 7.248 (s, 1H NMR (300 MHz, CDCl3): d 5.28 (s, 2H), 5.53 (s, 2H), 7.09 (d,
2H), 7.30–7,36 (m, 2H), 7.47 (m, 1H), 7.72 (d, 2H, J ¼ 8 Hz), 7.74 2H, J ¼ 8.4 Hz), 7.24 (d, 2H, J ¼ 8.4 Hz), 7.36 (d, 2H, J ¼ 8.4 Hz),
(s, 1H); 13C NMR (75.4 MHz, CDCl3): d 21.28(CH3), 51.41(CH2), 7.59 (s, 1H), 7.83 (d, 2H, J ¼ 8.7 Hz), 9.89 (s, 1H); 13C NMR (75.4
119.46 (ArCH), 125.64 (ArCH), 127.63(ArCH), 129.50 (ArCH), MHz, CDCl3): d 53.58 (CH2), 62.14 (CH2), 115.07 (ArCH), 122.77
129.91 (ArCH), 130.20(ArCH), 130.25 (ArCH), 132.61 (ArC), (ArCH), 129.41 (ArCH), 129.46 (ArCH), 130.40 (ArC), 131.99
133.42 (ArC), 138.08 (ArC), 148.23 (ArC); HRMS: mass calculated (ArCH), 132.80 (ArC), 135.01 (ArC) 143.84 (ArC), 163.08 (ArC),
for [C16H14ClN3]: 284.0955 [M + H]+ and 306.0774 [M + Na]+; obs. 190.75 (CHO); HRMS: mass calculated for [C17H14ClN3O2]:
mass: 284.0949 [M + H]+ and 306.0768 [M + Na]+.
328.0853 [M + H]+; obs. mass: 328.0847 [M + H]+.
2-(1-(4-Chlorobenzyl)-1H-1,2,3-triazol-4-yl) pyridine, 4bc.
4-((1-(4-Fluorobenzyl)-1H-1 2 3-triazol-4-yl)methyl) benzal-
Pale yellow solid; M.P.: 115–117 ꢁC; IR (neat): 2917, 2848, 2342, dehyde, 4cd. White solid; M.P.: 101–104 ꢁC; IR (neat): 3129,
1716, 1683, 1594, 1540, 1430, 1344, 1228, 1079, 995, 783, 765, 2844, 1683, 1603, 1540, 1457, 1231, 1222, 1131, 1110, 744 cmꢀ1
;
1
740 cmꢀ1; H NMR (300 MHz, CDCl3): d 5.58 (s, 2H), 7.25–7.39 1H NMR (300 MHz, CDCl3): d 5.27 (s, 2H), 5.52 (s, 2H), 7.09 (d,
(m, 5H), 7.80–7.86 (m, 1H), 8.17 (s, 1H), 8.22 (d, 1H, J ¼ 8.1 Hz), 4H, J ¼ 7.8), 7.29 (s, 2H), 7.57 (s, 1H), 7.83 (d, 2H, J ¼ 8.1 Hz),
8.56 (d, 1H, J ¼ 3.6 Hz); 13C NMR (75.4 MHz, CDCl3): d 3.67 9.89 (s, 1H, CHO); 13C NMR (75.4 MHz, CDCl3): d 53.57 (CH2),
(CH2), 120.61 (ArCH), 122.51 (ArCH), 123.12 (ArCH), 129.40 62.16 (CH2), 115.07 (ArCH), 116.07 (ArCH), 116.36 (ArCH),
(ArCH), 129.60 (ArCH), 132.81 (ArC), 134.98 (ArC), 137.83 122.70 (ArCH),129.99 (ArC), 130.10 (ArCH), 130.40 (ArC), 131.97
(ArCH), 147.89 (ArC), 148.85 (ArCH), 149.49 (ArC); HRMS: mass (ArC), 143.76 (ArC), 163.09 (ArC), 190.72 (CHO); HRMS: mass
calculated for [C14H11ClN4]: 271.0750 [M + H]+ and 293.0570 [M calculated for [C17H14FN3O2]: 312.1148 [M + H]+ and 334.0968
+ Na]+; obs. mass: 271.0745 [M + H]+ and 293.0564 [M + Na]+.
[M + Na]+; obs. mass: 312.1143 [M + H]+ and 334.0962 [M + Na]+.
2-(1-(2-Chlorobenzyl)-1H-1,2,3-triazol-4-yl) pyridine, 4fc. Pale
4-((1-(4-Methylbenzyl)-1H-1,2,3-triazol-4-yl)methyl) benzal-
yellow solid; M.P.: 107–110 ꢁC; IR (neat): 3160, 3050, 1716, 1680, dehyde, 4dd. Off white solid; M.P.: 118–122 ꢁC; IR (neat): 3145,
1
1604, 1434, 1355, 1226, 1193, 1088, 1072, 994 cmꢀ1; H NMR 3095, 2890, 1693, 1643, 1623, 1555, 1465, 1248, 1200, 745 cmꢀ1
;
(300 MHz, CDCl3): d 5.73 (s, 2H), 7.21–7.35 (m, 4H), 7.44 (d, 1H, 1H NMR (300 MHz, CDCl3): d 2.36 (s, 3H), 5.26 (s, 2H), 5.50 (s,
J ¼ 7.5 Hz), 7.76–7.82 (m, 1H), 8.19 (s, 1H), 8.21 (m, 1H), 8.56 (m, 2H), 7.09 (d, 2H, J ¼ 8.7 Hz), 7.20 (s, 4H), 7.55 (s, 1H), 7.83 (d,
This journal is © The Royal Society of Chemistry 2014
RSC Adv., 2014, 4, 42137–42146 | 42143